MediPharm Labs Corp. (TSE:LABS – Get Free Report) traded up 9.1% during mid-day trading on Friday. The stock traded as high as C$0.06 and last traded at C$0.06. Approximately 131,597 shares traded hands during mid-day trading, a decline of 33% from the average daily volume of 195,191 shares. The stock had previously closed at C$0.06.
MediPharm Labs Stock Performance
The company has a debt-to-equity ratio of 0.90, a quick ratio of 3.10 and a current ratio of 2.66. The stock has a 50 day moving average of C$0.07 and a 200 day moving average of C$0.07. The stock has a market capitalization of C$25.63 million, a P/E ratio of -6.00 and a beta of -0.60.
About MediPharm Labs
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Further Reading
- Five stocks we like better than MediPharm Labs
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
- Cracks in the Crockery? Williams-Sonoma Insiders Sell Shares
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
